Article
Soluble expression of bioactive recombinant porcine-human chimeric uricase mutant employing MBP-SUMO fusion system.
Protein expression and purification - 1 Jan 2022
Zhou Zhenlong, Zhao Hui, Zhang Ligang, Xie Qiuling, Liu Qiwei, Tong Mingjie, Yu Xiangwei, Xiong Sheng
Abstract excerpt
Urate oxidase is a promising biological medicine for hyperuricemia treatment, but immunogenicity obstructs the development of its clinical application. The recombinant porcine-human chimeric uricase mutant named dHU-wPU is a humanized chimeric uricase based on wild porcine uricase (wPU), which can effectively reduce the limitation of potential immunogenicity with a high homology (92.76%) to deduced human uricase...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
